ornithylaspartate has been researched along with Cruveilhier-Baumgarten Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsahhar, JS; Rahimi, RS | 1 |
| Dobkes, AL; Ermolov, SIu; Ermolova, TV; Kolesnikov, ME; Ovchinnikova, EV; Shabrov, AV | 1 |
1 review(s) available for ornithylaspartate and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Frailty; Gastrointestinal Agents; Gastrointestinal Microbiome; Glycerol; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Rifaximin; Trace Elements; Zinc | 2019 |
1 other study(ies) available for ornithylaspartate and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
[New approach to diagnostics and correction of portohepatic hemodynamics in patients with chronic liver diseases].
Topics: Adult; Dipeptides; Female; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Hypertension, Portal; Liver Circulation; Male; Retrospective Studies; Treatment Outcome | 2007 |